Objective: The objective of this study was to evaluate HIV postexposure prophylaxis (PEP) protocol in rape victims. Study: The victims were assigned to 1 of 3 categories, according to the severity of exposure (I-low, II-moderate, III-high). HIV PEP was provided to victims in groups II (Zdv + 3TC) and III (Zdv + 3TC + PI) until 72 hours after exposure. The follow-up was 6 months. Results: From May 1997 to October 2001, 347 victims were attended. PEP was offered to 278 victims (141 in group II and 137 in group III). Side effects were more common in group III (P <0.01). No seroconversion was diagnosed in the 180 victims that completed the follow-up. Univariate analysis showed that the schooling level, knowledge of the aggressor's HIV status, and the use of PEP were associated with compliance. Conclusions: Triple therapy was associated with side effects, which suggested that drug regimes should be reviewed. The variables related to a high risk of HIV transmission were also significant for compliance. Copyright © 2005, American Sexually Transmitted Diseases Association All rights reserved.324214219Tsai, C.C., Follis, K.E., Sabo, A., Prevention of SIV infection in macaques by (R)-9-(2- phosphonylmethoxypropyl) adenine (1995) Science, 270, pp. 1197-1199Sperling, R.S., Shapiro, D.E., Coombs, R.W., Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant (1996) N Engl J Med, 335, pp. 1621-1629Cardo, D.M., Culver, D.H., Ciessielski, C.A., A case-control study of HIV seroconversion in health care workers after percutaneous exposure (1997) N Engl J Med, 337, pp. 1542-1543Update. US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis (2001) MMWR Morb Mortal Wkly Rep, 50 (RR-11), pp. 1-42Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-17), pp. 1-14Myles, J.E., Bamberger, J., (2001) Offering HIV Prophylaxis Following Sexual Assault: Recommendations for the State of California, , http://hivinsite.ucsf.edu/pdf/pepassault.pdfLaporte, A., Jourdan, N., Bouvet, E., Post-exposure prophylaxis after non-occupational HIV exposure: Impact of recommendations on physicians' experiences and attitudes (2002) AIDS, 16, pp. 397-405Cohen, M.S., Eron, J.J., Sexual HIV transmission and its prevention HIV Medscape HIV/AIDS Clinical Management Modules, 18. , www.medscape.com/Medscape/HIV/ClinicalMgmt/CM.v18/public/index-CM.v18. htmlKahn, J.O., Martin, J.N., Roland, M.E., Feasibility of post-exposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study (2001) J Infect Dis, 183, pp. 707-714Katz, M., Gerberding, J.L., The care of persons with recent sexual exposure to HIV (1998) Ann Intern Med, 128, pp. 306-312Fong, C., Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated? (2001) Emerg Med J, 18, pp. 242-245Recommendations for non-occupational postexposure prophylaxis for HIV (2002) Enferm Infecc Microbiol Clin, 20, pp. 391-400Almeda, J., Casabona, J., Simon, B., Proposed Recommendations for the Management of HIV Post-exposure Prophylaxis after Sexual, Injecting Drug or Other Exposures in Europe, , http://www.eurosurveillance.org/em/v09n06/0906-223.asp1998 Guidelines for treatment of sexually transmitted diseases (1998) MMWR Morb Mortal Wkly Rep, 47 (RR-1), pp. 1-116Fleming, D., Wasserheit, J., From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection (1999) Sex Transm Infect, 75, pp. 3-17Cummins Jr., J., Dezzutti, C.S., Sexual HIV-1 transmission and mucosal defense mechanisms (2000) AIDS Rev, 2, pp. 144-154Nicolosi, A., Correa Leite, M., Musicco, M., The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: A study of 730 stable couples (1994) Epidemiology, 5, pp. 570-575. , Italian Study Group on HIV Heterosexual TransmissionPadian, N., Shiboski, S., Glass, S., Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study (1997) Am J Epidemiol, 146, pp. 350-357Vittinghoff, E., Douglas, J., Judson, F., Per-contact risk of human immunodeficiency virus transmission between male sexual partners (1999) Am J Epidemiol, 150, pp. 306-311Mastro, T.D., De Vincenzi, I., Probabilities of sexual HIV-1 transmission (1996) AIDS, 10 (SUPPL. A), pp. S75-S82Tsai, C.-C., Emau, P., Folis, K.E., Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIV mne depends critically on timing of initiation and duration of treatment (1998) J Virol, 72, pp. 4265-4273Skov, T., Deddens, J., Petersen, M.R., Prevalence proportion ratios: Estimation and hypothesis testing (1998) Int J Epidemiol, 27, pp. 91-95Kerr, E., Cottee, C., Chowdhury, R., Jawad, R., Welch, J., The Haven: A pilot referral centre in London for cases of serious sexual assault (2003) Br J Obstet Gynaecol, 110, pp. 267-271Limb, S., Kawsar, M., Forster, G.E., HIV post-exposure prophylaxis after sexual assault: The experience of a sexual assault service in london (2002) Int J STD AIDS, 13, pp. 602-605Meel, B.L., HIV/AIDS Post-exposure prophylaxis for victims of sexual assault attending Umtata General Hospital, South Africa (2004) Med Gen Med, 6. , XV International AIDS Conference Bangkok, Thailand, 2004 WePeB5847Vitavasiri, C., Kendornfake, S., Tapanayantra, M., Post exposure prophylaxis of HIV infection in sexually abused children (2004) Med Gen Med, 6. , XV International AIDS Conference Bangkok, Thailand, 2004 TuPeC4747Roland, M.E., Martin, J.N., Grant, R.M., Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure (2001) J Infect Dis, 184, pp. 1608-1612Coombs, R.W., Speck, C.E., Hughes, J.P., Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood (1998) J Infect Dis, 177, pp. 320-330Hart, C., Lennox, J., Pratt-Palmore, M., Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract (1999) J Infect Dis, 179, pp. 871-882Cohen, M., Hoffman, I., Royce, R., Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implication for prevention of sexual transmission of HIV-1 (1997) Lancet, 349, pp. 1868-1873. , AIDSCAP Malawi Research GroupUvin, S., Hogan, J., Caliendo, A., Bacterial vaginosis decreases suppression of female genital tract HIV-1 RNA levels (2000) 7th Conference on Retroviruses and Opportunistic Infections, , San Francisco, CAGrosskurth, H., Mosha, F., Todd, J., Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial (1995) Lancet, 346, pp. 530-536Gostin, L.O., Lazzarini, Z., Alexander, D., HIV testing, counseling, and prophylaxis after sexual assault (1994) JAMA, 271, pp. 1436-1444Gore, S.M., Bird, A.G., Burns, S., Anonymous HIV surveillance with risk factor elicitation: At Perth (for men) and Cornton Vale (for women) prisons in Scotland (1997) Int J STD AIDS, 8, pp. 166-175Holmes, M.M., Resnick, H.S., Frampton, D., Follow-up of sexual assault victims (1998) Am J Obstet Gynecol, 179, pp. 336-342Silberman, B., Salmon, D., Questel, F., Anti HIV chemoprophylaxis in the context of accidental sexual exposure by rape (2001) 8th Conference on Retroviruses and Opportunistic Infections, , ChicagoSoussy, A., Launay, O., Aubert, M., Caudron, J., Post sexual exposure prophylaxis with HAART after sexual assaults (2001) 8th Conference on Retroviruses and Opportunistic Infections, , Chicago(1992) Rape in America: A Report to the Nation, p. 287. , Charleston, SC: National Victim Center and Crime Victims Research and Treatment Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina